文献速递新生儿儿童神经与发育行为

机器学习算法识别新生儿惊厥的多中心随机对照试验

A machine-learning algorithm for neonatal seizure recognition: a multicentre, randomised, controlled trial.
PubMed 文献 · Lancet Child Adolesc Health · 2020-08-27

这项多中心随机对照试验评估了自动惊厥检测算法ANSeR对医护人员识别新生儿脑电图惊厥的诊断准确性。

核心结论

  • ANSeR算法安全且能准确检测新生儿惊厥,虽未提高个体新生儿识别,但改善了惊厥小时的识别。

研究设计与样本

  • 多中心、随机、双臂、平行对照试验,在爱尔兰、荷兰、瑞典和英国的8个新生儿中心进行。
  • 纳入胎龄36-44周、有惊厥或高风险需EEG监测的新生儿,随机分为算法组(cEEG+ANSeR)和非算法组(仅cEEG)。

关键数值与推荐

  • 主要结局为医护人员识别惊厥新生儿和惊厥小时的诊断准确性(敏感性、特异性和误检率)。
  • 惊厥小时定义为发生惊厥的小时数,共识别659小时(算法组268小时,非算法组391小时)。

临床怎么用

  • ANSeR算法可作为辅助工具改善惊厥小时的识别,尤其在经验较少的中心可能获益更大。
  • 算法未提高识别惊厥新生儿的敏感性,临床仍需结合常规EEG判读。

局限性

  • 研究未报告算法在经验较少中心的亚组分析结果,需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the availability of continuous conventional electroencephalography (cEEG), accurate diagnosis of neonatal seizures is challenging in clinical practice. Algorithms for decision support in the recognition of neonatal seizures could improve detection. We aimed to assess the diagnostic accuracy of an automated seizure detection algorithm called Algorithm for Neonatal Seizure Recognition (ANSeR). METHODS: This multicentre, randomised, two-arm, parallel, controlled trial was done in eight neonatal centres across Ireland, the Netherlands, Sweden, and the UK. Neonates with a corrected gestational age between 36 and 44 weeks with, or at significant risk of, seizures requiring EEG monitoring, received cEEG plus ANSeR linked to the EEG monitor displaying a seizure probability trend in real time (algorithm group) or cEEG monitoring alone (non-algorithm group). The primary outcome was diagnostic accuracy (sensitivity, specificity, and false detection rate) of health-care professionals to identify neonates with electrographic seizures and seizure hours with and without the support of the ANSeR algorithm. Neonates with data on the outcome of interest were included in the analysis. This study is registered with ClinicalTrials.gov, NCT02431780. FINDINGS: Between Feb 13, 2015, and Feb 7, 2017, 132 neonates were randomly assigned to the algorithm group and 132 to the non-algorithm group. Six neonates were excluded (four from the algorithm group and two from the non-algorithm group). Electrographic seizures were present in 32 (25·0%) of 128 neonates in the algorithm group and 38 (29·2%) of 130 neonates in the non-algorithm group. For recognition of neonates with electrographic seizures, sensitivity was 81·3% (95% CI 66·7-93·3) in the algorithm group and 89·5% (78·4-97·5) in the non-algorithm group; specificity was 84·4% (95% CI 76·9-91·0) in the algorithm group and 89·1% (82·5-94·7) in the non-algorithm group; and the false detection rate was 36·6% (95% CI 22·7-52·1) in the algorithm group and 22·7% (11·6-35·9) in the non-algorithm group. We identified 659 h in which seizures occurred (seizure hours): 268 h in the algorithm versus 391 h in the non-algorithm group. The percentage of seizure hours correctly identified was higher in the algorithm group than in the non-algorithm group (177 [66·0%; 95% CI 53·8-77·3] of 268 h vs 177 [45·3%; 34·5-58·3] of 391 h; difference 20·8% [3·6-37·1]). No significant differences were seen in the percentage of neonates with seizures given at least one inappropriate antiseizure medication (37·5% [95% CI 25·0 to 56·3] vs 31·6% [21·1 to 47·4]; difference 5·9% [-14·0 to 26·3]). INTERPRETATION: ANSeR, a machine-learning algorithm, is safe and able to accurately detect neonatal seizures. Although the algorithm did not enhance identification of individual neonates with seizures beyond conventional EEG, recognition of seizure hours was improved with use of ANSeR. The benefit might be greater in less experienced centres, but further study is required. FUNDING: Wellcome Trust, Science Foundation Ireland, and Nihon Kohden.

来源:Lancet Child Adolesc Health,查看原文。版权归原作者所有。

引用

  1. Pavel AM, Rennie JM, de Vries LS, et al. A machine-learning algorithm for neonatal seizure recognition: a multicentre, randomised, controlled trial. Lancet Child Adolesc Health. 2020. PMID: 32861271. doi:10.1016/S2352-4642(20)30239-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。